PLG and lung carcinoma: Another clinical study showed that patients with lung cancer had significantly higher levels of thrombin-antithrombin complexes III, D-dimer, and plasmin-alpha 1-antiplasmin complexes compared with nonmalignant populations, suggesting an increased activation of coagulation and fibrinolysis [42].